Dips Bioscience Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.65 Cr
- Company Age 17 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 25.23 Cr
- Revenue Growth 19.82%
- Profit Growth 69.94%
- Ebitda 58.62%
- Net Worth 25.12%
- Total Assets 22.52%
About Dips Bioscience
Dips Bioscience Private Limited (DBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 26 July 2007 and has a history of 17 years and six months. Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Dips Vetcare Genevet Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.65 Cr.
The company currently has active open charges totaling ₹25.23 Cr.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290MH2007PTC172630
-
Company No.
172630
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Jul 2007
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Dips Bioscience Private Limited offer?
Dips Bioscience Private Limited offers a wide range of products and services, including Animal Feed Enzymes, Phytase Enzyme, Health Drinks, Boost Health Drink, Nutritional Supplements, Nutritional Vitamin Supplements, Veterinary Medicines, Veterinary Drugs.
Who are the key members and board of directors at Dips Bioscience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shrikant Kulkarni
|
Director | 26-Jul-2007 | Current |
|
Neeta Kulkarni
|
Director | 26-Jul-2007 | Current |
Financial Performance of Dips Bioscience.
Dips Bioscience Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.82% increase. The company also saw a substantial improvement in profitability, with a 69.94% increase in profit. The company's net worth Soared by an impressive increase of 25.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dips Bioscience?
In 2023, Dips Bioscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹25.23 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 24.83 Cr
- Corporation Bank : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Oct 2015 | Corporation Bank | ₹4.00 M | Open |
| 11 Oct 2007 | Others | ₹24.83 Cr | Open |
How Many Employees Work at Dips Bioscience?
Dips Bioscience has a workforce of 58 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dips Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dips Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
